E-drug: World Bank meeting on Generic Drugs June 24-25
-------------------------------------------------------------------------
There will some changes, but this is the most recent version of the
agenda for the June 24-25 World Bank meeting on the role of generic
drugs. People who want to attend this event can register with Aida
Tapalova or Joy Spencer:
Aida Tapalova <atapalova@worldbank.org>
Joy Spencer <joy.spencer@cptech.org>
------
Provisional Agenda (Version: 6-4-2003) of the Final Meeting of the
World Bank consultation process on The Role of Generics and Local
Industry in Attaining the MDGs in Pharmaceuticals and Vaccines
June 24-25, 2003. The World Bank, Washington DC
Scope and purpose:
The endorsement by the World Bank and other international
organizations of the MDGs as the appropriate framework for
development assistance activities calls for a sectoral analysis of the
roles that each sector has to play in order to best contribute to these
goals and not to become a bottleneck to its achievement. This
meeting is aimed at presenting and discussing a comprehensive set
of options that countries and international organizations should
consider when designing their pharmaceutical strategies for
improving access to drugs in developing countries, especially among
the poor, and to identify the required interventions to be carried out at
both global and national level. In some cases, policy makers will be
able to choose among strategies and mechanisms that might have
been previously applied, sometimes successfully, in some countries.
Often, innovative approaches will have to be developed in order to
address new challenges or the failure of previous approaches.
The meeting will pay an special attention to the role of generics and
local production, two issues that have been relatively neglected in
the recent policy debates, almost exclusively centered on the role of
multinational companies and on intellectual property rights. The main
purpose of the meeting is therefor to identify the role and
opportunities for the World Bank in these two areas.
The morning session of the first day will be devoted to presenting the
conclusions of the consultation process, including, the June 2
Workshop. The presentations will concentrate on the main problems
identified, as well as the information gaps. In the afternoon session
country experiences on generic policies and local production will be
presented and discussed. Speakers will focus on lessons learned
than can be useful for other countries. Finally, a panel of World Bank
staff will discuss the implications of the topics addressed for Bank�s
policies and operational activities.
The second day will begin with a proposal of strategy options outlined
by the Generics Consultative group. The participants will then split
into several thematic groups for an in-depth discussion and review of
the previous proposal. The groups will report back in the final plenary
session that will end with a proposal and discussion of a future action
and research agenda.
PROVISIONAL PROGRAM
Tuesday, June 24
8.30-9:00 Registration
9:00-9:30 Opening Remarks
9:30-10:00 MDGs and pharmaceuticals
10:00-10:15 Coffee break
10:15-11.45 Key Issues
- Generic policies and regulation (Enrique Seoane, Ohio State
University)
- Procurement (James Fitzgerald, Pan American Health
Organization/WHO)
- Intellectual Property Rights (Carsten Fink, The World Bank)
- Production (Warren Kaplan, Boston University)
- Differential pricing (Juan Rovira, The World Bank)
11.45- 1.00 Country Experiences:
USA: Stephen Schondelmeier (University of Minnesota)
Costa Rica: Albin Chaves
Argentina: Lucas Godoy Garrazza or Graciela Ventura (Ministerio
de Salud)
Brazil: Dr. Jose Alberto Hermogenes de Souza, Secretaria de
Ciencia, Tecnologia e Insumos Estrategicos del Ministerio de la
Salud
Peru: Roberto Lopez (HAI)
LAC: Nuria Homedes (University of Texas)
1.00-2.00 Lunch
2.00-3.30 Country Experiences (cont):
India: Dilip Shah
Bangladesh: Zafrullah Chowdhury
South Africa: Jonathan Berger
Other countries
Discussion of country experiences
3.30-4.00 Coffee break
4.00-5.00 World Bank panel: Needs and perspectives from the
Regions (6 speakers)
5.00-5.30 Discussion
Wednesday, June 25
9:00-10:00 Plenary session
Generic Consultative Group: Presentation of Options Paper on The
Role of the Generics and Local Industry in Attaining the MDGs (Juan
Rovira)
- Global issues
- National policies
- The role of the World Bank
General discussion
10:00-12:30 Working groups. Discussion of implications for Bank's
policies and operations (5 parallel sessions)
- Generic policies and regulation.
- Procurement.
- Intellectual Property Rights
- Production
- Differential pricing
Participants will be allocated to one group. The last 30 participants
(except the chair and the rapporteur) will be allowed to move around
to other groups.
12:30-2.00 Lunch
2:00-3:00 Working groups reporting back to plenary
3:00-3.30 Discussion
3:30-4:30 Future agenda and conclusions
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug